Advertisement
Screener

Onconetix, Inc. (ONCO) Investment Interest Rate Paid In Kind

1.2 / 5 stars · 8/34 Roast Me

Onconetix, Inc. Investment Interest Rate Paid In Kind

Onconetix, Inc. (ONCO) had Investment Interest Rate Paid In Kind of 7.79% as of 2024-12-31, per its 10-K filed 2025-06-02.

Financial Statements › Notes › Schedule of Investments › Investment Interest and Dividend, Rate

us-gaap:InvestmentInterestRatePaidInKind · last filed 2025-06-02

  • 2024-12-31: Investment Interest Rate Paid In Kind 7.79%.
  • 2024-09-30: Investment Interest Rate Paid In Kind 7.79%.
  • 2024-06-30: Investment Interest Rate Paid In Kind 7.79%.
  • 2024-03-31: Investment Interest Rate Paid In Kind 7.79%.
Period endInvestment Interest Rate Paid In Kind
2024-12-317.79%
10-K · filed 2025-06-02
2024-09-307.79%
10-Q · filed 2024-12-10
2024-06-307.79%
10-Q · filed 2024-08-29
2024-03-317.79%
10-Q · filed 2024-05-20

Similar stocks

Stock NameCountryMarket CapPE Ratio
HCW Biologics Inc. (HCWB)United States$0.004B-6.15
REVELATION BIOSCIENCES, INC. (REVB)United States$0.004B
Aptevo Therapeutics Inc. (APVO)United States$0.003B
Sunshine Biopharma Inc. (SBFM)$0.003B
60 DEGREES PHARMACEUTICALS, INC. (SXTP)United States$0.004B-0.59
Alaunos Therapeutics, Inc. (TCRT)United States$0.003B-1.44
Genprex, Inc. (GNPX)United States$0.003B-0.02
Silo Pharma, Inc. (SILO)United States$0.003B-1.57
Lakewood-Amedex Biotherapeutics Inc. (LABT)United States$0.004B
Cadrenal Therapeutics, Inc. (CVKD)United States$0.004B-0.90